Q4 2025 · 13F-HR
ABG-WTT Global Life Science Capital Partners GP Ltdholdings as filed
Filed 2026-02-17 · accession 0001193125-26-055042
$15.0M
Reported value
2
Positions
2025-12-31
Period end
The Brief · ABG-WTT Global Life Science Capital Partners GP Ltd · Q4 2025
AI · grounded in 13F
ABG-WTT Global Life Science Capital Partners GP Ltd trimmed its position in CBLL by 59.4%. The fund held two positions at the end of the period with total assets under management of $15,049,171. No new positions were added during the quarter.
Holdings as filed
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.